-transparent.png){kind=logo}
Complement fixing (CF) antibodies to the AD--129 strain of human cytomegalovirus (HCMV) were detected in patients with different forms of cancer, as well as in blood donors, in a proportion of 16.6% and 73.2%, respectively. The prevalence of CF antibodies to HCMV, strain AT--129, in the population of Romania is similar to that reported in other countries.
Related Publications
M Stoian, and
M Hozoc, and
M Iosipenco, and
J Bolocan, and
E Nastac
November 1988,
Journal of clinical microbiology,
M Stoian, and
M Hozoc, and
M Iosipenco, and
J Bolocan, and
E Nastac
January 1976,
Trudy Leningradskogo nauchno-issledovatel'skogo instituta epidemiologii i mikrobiologii imeni Pastera,
M Stoian, and
M Hozoc, and
M Iosipenco, and
J Bolocan, and
E Nastac
January 1963,
Acta pathologica et microbiologica Scandinavica,
M Stoian, and
M Hozoc, and
M Iosipenco, and
J Bolocan, and
E Nastac
March 1989,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Stoian, and
M Hozoc, and
M Iosipenco, and
J Bolocan, and
E Nastac
March 1989,
The Journal of infectious diseases,
M Stoian, and
M Hozoc, and
M Iosipenco, and
J Bolocan, and
E Nastac
March 2000,
Clinical and diagnostic laboratory immunology,
M Stoian, and
M Hozoc, and
M Iosipenco, and
J Bolocan, and
E Nastac
October 1975,
Clinical and experimental immunology,
M Stoian, and
M Hozoc, and
M Iosipenco, and
J Bolocan, and
E Nastac
January 1981,
Neuropsychologia,
M Stoian, and
M Hozoc, and
M Iosipenco, and
J Bolocan, and
E Nastac
May 2004,
Autoimmunity,
M Stoian, and
M Hozoc, and
M Iosipenco, and
J Bolocan, and
E Nastac
March 1999,
Likars'ka sprava,
